Cargando…
Correction to: Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID‑19 era
Autores principales: | Toscano, Simona, Patti, Francesco, Chisari, Clara Grazia, Arena, Sebastiano, Finocchiaro, Chiara, Schillaci, Carmela Elita, Zappia, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787033/ https://www.ncbi.nlm.nih.gov/pubmed/35076808 http://dx.doi.org/10.1007/s10072-022-05905-3 |
Ejemplares similares
-
Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022) -
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022) -
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature
por: Patti, Francesco, et al.
Publicado: (2022) -
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
por: Chisari, Clara G., et al.
Publicado: (2021) -
Rituximab for the treatment of multiple sclerosis: a review
por: Chisari, Clara Grazia, et al.
Publicado: (2021)